Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency

American Journal of Physiology - Renal Physiology

Volumn 292, Issue 2, 2007, Pages

  Cohen, Margo P ^a,b   Lautenslager, Gregory T ^b   Hud, Elizabeth ^a,b   Shea, Elizabeth ^a,b   Wang, Amy ^c   Chen, Sheldon ^c   Shearman, Clyde W ^b  

^a The Science Center Philadelphia   (United States)

^b Glycadia Inc ^*  (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Diabetes; Glycated albumin

Indexed keywords

2 (3 CHLOROPHENYLAMINO)PHENYLACETIC ACID; COLLAGEN TYPE 4; CREATININE; GLUCOSE; GLYCOSYLATED ALBUMIN; NEPHRIN; PHENYLACETIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FAILURE; MALE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

EID: 33846875250     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00201.2006     Document Type: Article

References (42)

1. Adamczak M, Gross ML, Amann K, Ritz E. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature. J Am Soc Nephrol 15: 3063-3072, 2004.
2. Adler SG, Feld S, Striker L, Striker G, LaPage J, Esposito C, Aboulhosn J, Barba L, Cha DR, Nast CC. Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease. Kidney Int 57: 2084-2092, 2000.
3. Benigni A, Zoja C, Corna D, Zatelli C, Conti S, Campana M, Gagliardini E, Rottoli D, Zanchi C, Abbate M, Ledbetter S, Remuzzi G. Add-on anti-TGF-β antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat. J Am Soc Nephrol 14: 1816-1824, 2003.
4. Bussolati B, Dunk C, Grohman M, Kontos CD, Mason J, Ahmed A. Vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 159: 993-1008, 2001.
5. Carmeliet P, Moons L, Lutton A, Vincenti V, Compernolle V, De Mol M, Wu Yan Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7: 575-583, 2001.
6. Chen S, Cohen MP, Lautenslager GT, Shearman CW, Ziyadeh FN. Glycated albumin stimulates TGF-β1 production and protein kinase activity in glomerular endothelial cells. Kidney Int 59: 673-681, 2001.
7. 3(IV) collagen production by transforming growth factor β1 in mouse podocytes. Diabetes 53: 2939-2949, 2004.
8. 3(IV) II collagen production in mouse podocytes via TGF-β and VEGF signaling: implications for diabetic glomerulopathy. Nephrol Dial Transplant 20: 1320-1328, 2005.
9. Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, Shearman CW. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy. Kidney Int 68: 1554-1561, 2005.
10. Cohen MP, Clements RS, Hud E, Cohen JA, Ziyadeh FN. Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy. Exp Nephrol 4: 166-171, 1996.
11. Cohen MP, Sharma K, Jin Y, Hud E, Wu VY, Tomaszewski J, Ziyadeh FN. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. J Clin Invest 95: 2338-2345, 1995.
12. Cohen MP, Shea EA, Shearman CW. ERK mediates effects of glycated albumin in mesangial cells. Biochem Biophys Res Commun 283: 641-643, 2001.
13. Cohen MP, Ziyadeh FN. Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. Kidney Int 45: 475-484, 1994.
14. Cohen MP, Ziyadeh FN, Hong SW, Shearman CW, Hud E, Lautenslager M, Iglesias-de la Cruz C, Chen C. Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-β1. Kidney Int 61: 2025-2032, 2002.
15. Cohen MP, Ziyadeh FN, Lautenslager GT, Cohen JA, Shearman CW. Glycated albumin stimulation of PKC-β activity is linked to increased collagen IV production in mesangial cells. Am J Physiol Renal Physiol 276: F684-F690, 1999.
16. Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, Casley DJ, Bach LA, Kelly DJ, Gilbert RE. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGF-R2 in experimental diabetes. Diabetes 48: 2229-2239, 1999.
17. Dahly AJ, Hoagland KM, Flasch AK, Jha S, Ledbetter S, Roman RJ. Anti-hypertensive effects of chronic anti-TGF-β1 antibody therapy in Dahl S rats. Am J Physiol Regul Integr Comp Physiol 283: R757-R767, 2002.
18. DeVriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12: 993-1000, 2001.
19. Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Defarrari G, Camussi G. Nephrin expression is reduced in human diabetic nephropathy. Diabetes 52: 1023-1030, 2003.
20. Dunn SR, Qi Z, Bottinger EP, Breyer M, Sharma K. Utility of endogenous creatinine clearance as a measure of renal function in mice. Kidney Int 65: 1959-1967, 2004.
21. Flyvbjerg A, Dagnaes-Hansen F, DeVriese AS, Schrijvers BF, Tilton RG, Rasch R. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51: 3090-3094, 2002.
22. Funabiki K, Makita Y, Yamamoto M, Shike T, Fukui M, Simiyoshi Y, Tomino Y. Dissociated expression of collagen type IV subchains in diabetic kidneys of KKAy mice. Nephron 80: 208-213, 1998.
23. Hiratsuka S, Maru Y, Okada A, Seiku M, Noda T, Shibuya M. Involvement of flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. Cancer Res 61: 1207-1213, 2001.
24. Hostetter TH. Prevention of end-stage renal disease due to type 2 diabetes. N Engl J Med 354: 910-911, 2001.
25. Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. Diabetes 54: 2891-2903, 2005.
26. Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S. Effects of high glucose and TGF-β1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 62: 901-913, 2002.
27. Kakizawa H, Itoh Y, Imamura S, Matsumoto T, Ishiwata Y, Ono Y, Yamamoto K, Kato T, Hayakawa N, Oda N, Goto Y, Goto Y, Nagasaka A, Senda T, Itoh M. Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and angiotensin II receptor antagonist. Horm Metab Res 36: 458-464, 2004.
28. Kalender B, Ozturk T, Tuncdemir M, Uysal O, Dagistanli FK, Yegenaga I, Erek E. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats. Acta Histochem 104: 123-130, 2002.
29. King H, Aubert R, Herman W. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projection. Diabetes Care 21: 1414-1431, 1998.
30. Lau K, Eby B. Amelioration of diabetic nephropathy in db/db mice by an adenovirus carrying the gene for pigment epithelium-derived factor (PEDF), an anti-angiogenic anti-inflammatory protein normally expressed by the glomerulus. Am Soc Nephrol Abst TH-FC011, 2005.
31. Lee EY, Shim MS, Kim MJ, Hong SY, Shin YG, Chung CH. Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes. Exp Mol Med 29: 65-70, 2004.
32. 5) in experimental membranous nephropathy. Proc Assoc Am Physicians 110: 207-217, 1998.
33. National Institute of Diabetes and Digestive and Kidney Diseases. US Renal Data System, ESRDS 1999 Annual Data Report. Bethesda, MD: National Institutes of Health, 1999, p. 25-38.
34. Nozaki M, Sakurai E, Raisler BJ, Baffi JZ, Witta J, Ogura Y, Brekken RA, Sage EH, Ambati BK, Ambati J. Loss of SPARC-mediated VEGFR1 suppression after injury reveals a novel anti-angiogenic activity of VEGF-A. J Clin Invest 116: 422-429, 2006.
35. Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116: 288-296, 2006.
36. Rizkalla B, Forbes JM, Cao Z, Boner G, Cooper ME. Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system. J Hypertens 23: 153-164, 2005.
37. Sharma K, Jin Y, Guo J, Ziyadeh FN. Neutralization of TGFβ by anti-TGFβ antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mouse. Diabetes 45: 522-530, 1996.
38. Volpini RA, da Silva CG, Costa RS, Coimbra TM. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats. Diabetes Metab Res Rev 19: 43-51, 2003.
39. Yagame M, Kim Y, Zhu D, Suzuki D, Eguchi K, Nomoto Y, Sakai H, Groppoli T, Steffes MW, Mauer SM. Differential distribution of type IV collagen chains in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 70: 42-48, 1995.
40. Zeisberg M, Eriksen MB, Hamano Y, Neilson EG, Ziyadeh F, Kalluri R. Differential expression of type IV collagen isoforms in rat glomerular endothelial and mesangial cells. Biochem Biophys Res Commun 295: 401-407, 2002.
41. Ziyadeh FN, Han DC, Cohen JA, Guo J, Cohen MP. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the TGF-β1 system. Kidney Int 54: 631-638, 1998.
42. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-de la Cruz C, Hong SW, Isono M, Chen S, McGowan TA, Sharma K. Long-term prevention of renal insufficiency, excess matrix gene expression and glomerular mesangial matrix expression by treatment with monoclonal anti-TGF-β antibody in db/db mice. Proc Natl Acad Sci USA 97: 8015-8020, 2000.